Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TLA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,306
Award facts
- Contract value 100% obligated
- $14,306.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,306 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order represents a single shipment of this typhoid vaccine product, with performance to be completed by January 14, 2026, and fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2026, which provides the contracting vehicle for this and similar pharmaceutical and medical supply deliveries.
This delivery order falls under AmerisourceBergen's larger pharmaceutical prime vendor agreement with the DLA, which enables the company to supply a comprehensive range of medications, vaccines, and medical commodities to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The contract reflects AmerisourceBergen's established role as a primary federal supplier for essential medical products across multiple therapeutic domains, with the firm fixed-price structure ensuring cost certainty for this vaccine procurement.
Quick answers
Who was awarded contract SPE2DR26F3TLA?
SPE2DR26F3TLA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3TLA worth?
The government has obligated $14,306 on SPE2DR26F3TLA.
Is contract SPE2DR26F3TLA an order under another contract?
Yes. SPE2DR26F3TLA is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TLA competed?
The extent of competition for SPE2DR26F3TLA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award